HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 103 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $223,000 | -88.2% | 5,819 | -91.3% | 0.00% | -87.5% |
Q2 2021 | $1,885,000 | -35.9% | 66,761 | -24.9% | 0.01% | -33.3% |
Q1 2021 | $2,940,000 | -17.3% | 88,947 | -9.5% | 0.01% | -25.0% |
Q4 2020 | $3,553,000 | +10.8% | 98,276 | +3.9% | 0.02% | -23.8% |
Q3 2020 | $3,206,000 | – | 94,580 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Valor Management LLC | 11,218,033 | $394,762,581 | 98.29% |
venBio Partners LLC | 1,035,396 | $36,435,585 | 13.19% |
Nan Fung Group Holdings Ltd | 368,665 | $12,973,321 | 8.29% |
Vivo Capital, LLC | 2,606,247 | $91,713,832 | 6.33% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $20,070,190 | 6.11% |
Altium Capital Management LP | 149,889 | $5,274,594 | 3.99% |
AlphaCentric Advisors LLC | 118,000 | $4,152,420 | 2.30% |
ASHFORD CAPITAL MANAGEMENT INC | 449,038 | $15,801,647 | 2.21% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,240 | $22,389,286 | 2.05% |
TANG CAPITAL MANAGEMENT LLC | 271,200 | $9,543,528 | 1.40% |